Maternal care for disproportion (Code range O33.0 O33.9)- The following listed conditions leading to disproportion warrants observation, hospitalization or other obstetric care of the mother, or for cesarean delivery before onset of labor- Deformity of maternal pelvic bones Generally contracted pelvis Inlet contraction of pelvis Outlet contraction of pelvis Mixed maternal and fetal origin Unusually large fetus Hydrocephalic fetus Maternal care for abnormality of pelvic organs (Code range O34.00- O34.93)- The following listed abnormality of pelvic organs requires observation, hospitalization or other obstetric care of the mother, or for cesarean delivery before onset of labor- Congenital malformation of uterus Benign tumor of corpus uteri Uterine scar from previous surgery Cervical incompetence Incarceration, prolapse or retroversion of gravid uterus Abnormality of vagina Abnormality of vulva and perineum Maternal care for known or suspected fetal abnormality and damage (Code range O35.0XX0- O35.9XX9)- Conditions included are suspected- Central nervous system malformation in fetus Chromosomal abnormality in fetus Hereditary disease in fetus Damage to fetus from viral disease in mother Damage to fetus from alcohol Damage to fetus by drugs Damage to fetus by radiation Maternal care for other fetal problems (Code range O36.0110- O36.93X9)- Conditions included are- Rhesus isoimmunization Anti-A sensitization Other isoimmunization Hydrops fetalis (large amounts of fluid accumulation babys tissues and organs) Intrauterine death Suspected poor fetal growth Suspected placental insufficiency Excessive fetal growth Viable fetus in abdominal pregnancy Inconclusive fetal viability Decreased fetal movements Fetal anemia and thrombocytopenia Abnormalities of the fetal heart rate or rhythm Polyhydramnios (hydramnios) (Code range O40.1XX0- O40.9XX9)- An excess amount of amniotic fluid in the amniotic sac than the accepted normal values
APS has a few tips to help keep cooling costs down
As noted earlier, it was discovered somewhat upstream of the mouth of the Niobrara River on September 7, 1804, at a clay promontory the explorers described as "The Tower," located in what is now northern Boyd County
Harmalol had no effect on the release of NO from the endothelial cells and it weakly interacted with the cardiac 1,4-dihydropyridine binding site of L-type Ca 2+ channels (Ki value of 408 microM).[11] In the same study, the vasorelaxant activity of harman, another active alkaloid of P
Business development increased and joint stock companies began to organize for overseas settlement
